Baseline incidence of meningitis, malaria, mortality and other health outcomes in infants and young sub-Saharan African children prior to the introduction of the RTS,S/AS01E malaria vaccine

Table 1 Number of study participants by study site and by study group

Study site	Study group	Number of participants (%) per study site
Kombewa, Kenya N = 4219	6 to 12 weeks	1979 (46.9)
Kombewa, Kenya N = 4219	5 to 17 months	2240 (53.1)
Kintampo, Ghana N = 7952	6 to 12 weeks	4297 (54.0)
Kintampo, Ghana N = 7952	5 to 17 months	3655 (46.0)
Navrongo, Ghana N = 2158	6 to 12 weeks	972 (45.0)
Navrongo, Ghana N = 2158	5 to 17 months	1186 (55.0)

ISSN: 1475-2875